15-63601352-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_203373.3(FBXL22):āc.410C>Gā(p.Thr137Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,604,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_203373.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL22 | NM_203373.3 | c.410C>G | p.Thr137Ser | missense_variant | 2/2 | NP_976307.2 | ||
FBXL22 | NM_001367809.1 | c.*60C>G | 3_prime_UTR_variant | 3/3 | NP_001354738.1 | |||
FBXL22 | XM_047432400.1 | c.353+3607C>G | intron_variant | XP_047288356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL22 | ENST00000360587.2 | c.410C>G | p.Thr137Ser | missense_variant | 2/2 | 1 | ENSP00000353794.3 | |||
FBXL22 | ENST00000560325.1 | c.*60C>G | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000473666.1 | ||||
USP3-AS1 | ENST00000561256.5 | n.238G>C | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000376 AC: 9AN: 239270Hom.: 0 AF XY: 0.0000534 AC XY: 7AN XY: 131084
GnomAD4 exome AF: 0.0000248 AC: 36AN: 1451764Hom.: 0 Cov.: 32 AF XY: 0.0000277 AC XY: 20AN XY: 722260
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2024 | The c.410C>G (p.T137S) alteration is located in exon 2 (coding exon 2) of the FBXL22 gene. This alteration results from a C to G substitution at nucleotide position 410, causing the threonine (T) at amino acid position 137 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at